P
Peter Kruger
Researcher at Princess Alexandra Hospital
Publications - 91
Citations - 6626
Peter Kruger is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 25, co-authored 83 publications receiving 5789 citations. Previous affiliations of Peter Kruger include Alfred Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
The GROMOS Biomolecular Simulation Program Package
Walter R. P. Scott,Philippe H. Hünenberger,Ilario G. Tironi,Alan E. Mark,S. R. Billeter,Jens Fennen,Andrew E. Torda,Thomas Huber,Peter Kruger,W. F. van Gunsteren +9 more
TL;DR: The newest version of the GROningen MOlecular Simulation program package, GROMOS96, has been developed for the dynamic modelling of (bio)molecules using the methods of molecular dynamics, stochastic dynamics, and energy minimization as well as the path-integral formalism.
Journal Article
The GROMOS biomolecular simulation program package
Walter R. P. Scott,Philippe H. Hünenberger,Ilario G. Tironi,Alan E. Mark,S. R. Billeter,Jens Fennen,Andrew E. Torda,Peter Kruger,W. F. van Gunsteren,Thomas Huber +9 more
TL;DR: The GROningen MOlecular Simulation (GROMOS) program package as mentioned in this paper has been developed for the dynamic modeling of (bio)molecules using the methods of molecular dynamics, stochastic dynamics, and energy minimization as well as the path-integral formalism.
The GROMOS96 Manual and User Guide
W. F. van Gunsteren,S. R. Billeter,A.A. Eising,Philippe H. Hünenberger,Peter Kruger,Alan E. Mark,Walter R. P. Scott,Ilario G. Tironi,P.H. Huenenberger,P. Krueger +9 more
Journal ArticleDOI
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Derek C. Angus,Lennie P. G. Derde,Farah Al-Beidh,Djillali Annane,Yaseen M. Arabi,Abi Beane,Wilma van Bentum-Puijk,Lindsay R. Berry,Zahra Bhimani,Marc J. M. Bonten,Charlotte Bradbury,Frank M. Brunkhorst,Meredith Buxton,Adrian Buzgau,Allen C. Cheng,Menno de Jong,Michelle A. Detry,Lise J Estcourt,Lise J Estcourt,Mark Fitzgerald,Herman Goossens,Cameron Green,Rashan Haniffa,Alisa Higgins,Christopher M. Horvat,Sebastiaan J. Hullegie,Peter Kruger,Francois Lamontagne,Patrick R. Lawler,Kelsey Linstrum,Edward Litton,Elizabeth Lorenzi,John E. A. Marshall,John E. A. Marshall,Daniel F. McAuley,Anna McGlothin,Shay McGuinness,Shay McGuinness,Shay McGuinness,Bryan J. McVerry,Stephanie K. Montgomery,Paul R Mouncey,Srinivas Murthy,Alistair Nichol,Rachael Parke,Rachael Parke,Rachael Parke,Jane Parker,Kathryn M Rowan,Ashish Sanil,Marlene Santos,Christina Saunders,Christopher W. Seymour,Anne Turner,Frank L. van de Veerdonk,Balasubramanian Venkatesh,Balasubramanian Venkatesh,Ryan Zarychanski,Scott M. Berry,Roger J. Lewis,Roger J. Lewis,Colin McArthur,Steven A R Webb,Steven A R Webb,Steven A R Webb,Anthony C. Gordon +65 more
TL;DR: To determine whether hydrocortisone improves outcome for patients with severe COVID-19, an ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin was conducted.
Journal ArticleDOI
Antibiotic resistance : What's dosing got to do with it?
Jason A. Roberts,Peter Kruger,David L. Paterson,David L. Paterson,Jeffrey Lipman,Jeffrey Lipman +5 more
TL;DR: Antibiotic dosing must aim to address not only the bacteria isolated, but also the most resistant subpopulation in the colony, to prevent the advent of further resistant infections because of the inadvertent selection pressure of current dosing regimens.